IONS Financial Statements

Balance sheet, income statement, cash flow, and dividends for Ionis Pharmaceuticals Inc (IONS).


$5.52B Market Cap.

As of 02/19/2025 5:00 PM ET (MRY) • Disclaimer

IONS Market Cap. (MRY)


IONS Shares Outstanding (MRY)


IONS Assets (MRY)


Total Assets

$3.00B

Total Liabilities

$2.42B

Total Investments

$2.06B

IONS Income (MRY)


Revenue

$705.14M

Net Income

-$453.90M

Operating Expense

$1.17B

IONS Cash Flow (MRY)


CF Operations

-$500.95M

CF Investing

-$134.03M

CF Financing

$478.06M

IONS Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

IONS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$3,003,675,000 (0.45%)

$2,990,072,000 (18.00%)

$2,533,876,000 (-2.98%)

$2,611,690,000 (9.29%)

Assets Current

$2,620,290,000 (-0.82%)

$2,641,853,000 (19.94%)

$2,202,694,000 (-6.07%)

$2,345,049,000 (10.06%)

Assets Non-Current

$383,385,000 (10.10%)

$348,219,000 (5.14%)

$331,182,000 (24.21%)

$266,641,000 (2.93%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$588,351,000 (52.15%)

$386,686,000 (-32.50%)

$572,887,000 (-25.77%)

$771,737,000 (3.83%)

Property Plant & Equipment Net

$256,107,000 (5.42%)

$242,939,000 (-5.04%)

$255,838,000 (30.50%)

$196,043,000 (8.26%)

Cash & Equivalents

$242,077,000 (-39.37%)

$399,266,000 (44.41%)

$276,472,000 (-68.19%)

$869,191,000 (118.57%)

Accumulated Other Comprehensive Income

-$30,811,000 (5.62%)

-$32,645,000 (43.21%)

-$57,480,000 (-75.95%)

-$32,668,000 (-55.04%)

Deferred Revenue

$235,493,000 (-39.97%)

$392,312,000 (3.69%)

$378,345,000 (-15.85%)

$449,593,000 (-15.56%)

Total Investments

$2,055,579,000 (6.40%)

$1,931,935,000 (12.95%)

$1,710,397,000 (37.30%)

$1,245,782,000 (-16.65%)

Investments Current

$2,055,579,000 (6.40%)

$1,931,935,000 (12.95%)

$1,710,397,000 (37.30%)

$1,245,782,000 (-16.65%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$12,512,000 (-55.98%)

$28,425,000 (29.01%)

$22,033,000 (-11.18%)

$24,806,000 (12.93%)

Trade & Non-Trade Receivables

$92,188,000 (-5.72%)

$97,778,000 (282.87%)

$25,538,000 (-58.74%)

$61,896,000 (-18.78%)

Trade & Non-Trade Payables

$42,964,000 (65.07%)

$26,027,000 (45.23%)

$17,921,000 (50.55%)

$11,904,000 (-30.79%)

Accumulated Retained Earnings (Deficit)

-$2,249,808,000 (-25.27%)

-$1,795,911,000 (-25.62%)

-$1,429,625,000 (-23.25%)

-$1,159,903,000 (-2.53%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$34,000 (-98.42%)

$2,151,000 (-65.58%)

$6,249,000 (17258.33%)

$36,000 (-97.28%)

Total Debt

$1,407,290,000 (-2.59%)

$1,444,708,000 (6.10%)

$1,361,660,000 (9.15%)

$1,247,524,000 (32.77%)

Debt Current

$0 (0%)

$44,332,000 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$1,407,290,000 (0.49%)

$1,400,376,000 (2.84%)

$1,361,660,000 (9.15%)

$1,247,524,000 (100.07%)

Total Liabilities

$2,415,324,000 (-7.22%)

$2,603,386,000 (32.76%)

$1,960,989,000 (6.58%)

$1,839,953,000 (11.75%)

Liabilities Current

$309,318,000 (-30.97%)

$448,090,000 (43.82%)

$311,561,000 (29.52%)

$240,550,000 (-59.83%)

Liabilities Non-Current

$2,106,006,000 (-2.29%)

$2,155,296,000 (30.67%)

$1,649,428,000 (3.13%)

$1,599,403,000 (52.68%)

IONS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$705,138,000 (-10.48%)

$787,647,000 (34.10%)

$587,367,000 (-27.53%)

$810,456,000 (11.13%)

Cost of Revenue

$11,215,000 (22.80%)

$9,133,000 (-35.30%)

$14,116,000 (30.20%)

$10,842,000 (-9.25%)

Selling General & Administrative Expense

$267,474,000 (14.98%)

$232,619,000 (54.77%)

$150,295,000 (-19.35%)

$186,347,000 (-47.41%)

Research & Development Expense

$901,530,000 (0.21%)

$899,625,000 (7.98%)

$833,147,000 (29.48%)

$643,453,000 (20.25%)

Operating Expenses

$1,169,004,000 (3.25%)

$1,132,244,000 (15.13%)

$983,442,000 (18.52%)

$829,800,000 (-6.70%)

Interest Expense

$90,451,000 (11.04%)

$81,457,000 (902.92%)

$8,122,000 (-13.12%)

$9,349,000 (-1.69%)

Income Tax Expense

-$6,171,000 (-119.09%)

$32,321,000 (175.38%)

$11,737,000 (2230.13%)

-$551,000 (-100.16%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$453,897,000 (-23.92%)

-$366,286,000 (-35.80%)

-$269,722,000 (-843.18%)

-$28,597,000 (94.04%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$453,897,000 (-23.92%)

-$366,286,000 (-35.80%)

-$269,722,000 (-843.18%)

-$28,597,000 (93.56%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$453,897,000 (-23.92%)

-$366,286,000 (-35.80%)

-$269,722,000 (-843.18%)

-$28,597,000 (93.56%)

Weighted Average Shares

$149,514,000 (4.42%)

$143,190,000 (0.95%)

$141,848,000 (0.59%)

$141,021,000 (1.01%)

Weighted Average Shares Diluted

$149,514,000 (4.42%)

$143,190,000 (0.95%)

$141,848,000 (0.59%)

$141,021,000 (1.01%)

Earning Before Interest & Taxes (EBIT)

-$369,617,000 (-46.38%)

-$252,508,000 (-1.06%)

-$249,863,000 (-1162.00%)

-$19,799,000 (77.89%)

Gross Profit

$693,923,000 (-10.87%)

$778,514,000 (35.81%)

$573,251,000 (-28.31%)

$799,614,000 (11.47%)

Operating Income

-$475,081,000 (-34.31%)

-$353,730,000 (13.76%)

-$410,191,000 (-1258.88%)

-$30,186,000 (82.46%)

IONS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$134,027,000 (37.41%)

-$214,127,000 (18.47%)

-$262,636,000 (-234.75%)

$194,906,000 (-28.99%)

Net Cash Flow from Financing

$478,058,000 (-25.78%)

$644,082,000 (1264.81%)

-$55,295,000 (-122.48%)

$245,933,000 (141.22%)

Net Cash Flow from Operations

-$500,947,000 (-62.90%)

-$307,513,000 (-12.08%)

-$274,370,000 (-990.84%)

$30,799,000 (-14.19%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$157,189,000 (-228.01%)

$122,794,000 (120.72%)

-$592,719,000 (-225.70%)

$471,527,000 (265.09%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$83,686,000 (55.04%)

-$186,138,000 (62.52%)

-$496,620,000 (-333.37%)

$212,807,000 (-32.55%)

Capital Expenditure

-$45,280,000 (-90.39%)

-$23,783,000 (-109.98%)

$238,362,000 (2093.83%)

-$11,955,000 (65.96%)

Issuance (Repayment) of Debt Securities

-$167,000 (-100.03%)

$562,288,000 (1209.36%)

-$50,686,000 (-117.01%)

$297,961,000 (0%)

Issuance (Purchase) of Equity Shares

$522,729,000 (957.26%)

$49,442,000 (675.80%)

$6,373,000 (-93.71%)

$101,317,000 (363.08%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$273,000 (-177.56%)

$352,000 (184.21%)

-$418,000 (-276.58%)

-$111,000 (-117.99%)

Share Based Compensation

$130,200,000 (23.05%)

$105,809,000 (5.53%)

$100,264,000 (-16.92%)

$120,678,000 (-47.56%)

Depreciation Amortization & Accretion

$21,990,000 (-2.26%)

$22,498,000 (1.78%)

$22,105,000 (13.01%)

$19,560,000 (13.99%)

IONS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

98.40% (-0.40%)

98.80% (1.23%)

97.60% (-1.11%)

98.70% (0.30%)

Profit Margin

-64.40% (-38.49%)

-46.50% (-1.31%)

-45.90% (-1211.43%)

-3.50% (94.25%)

EBITDA Margin

-49.30% (-68.84%)

-29.20% (24.74%)

-38.80% (0%)

0% (0%)

Return on Average Equity (ROAE)

-100.30% (-10.71%)

-90.60% (-110.21%)

-43.10% (-857.78%)

-4.50% (87.67%)

Return on Average Assets (ROAA)

-15.70% (-26.61%)

-12.40% (-13.76%)

-10.90% (-808.33%)

-1.20% (92.11%)

Return on Sales (ROS)

-52.40% (-63.24%)

-32.10% (24.47%)

-42.50% (-1670.83%)

-2.40% (80.49%)

Return on Invested Capital (ROIC)

-10.00% (-44.93%)

-6.90% (15.85%)

-8.20% (-1071.43%)

-0.70% (77.42%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-11.5 (41.81%)

-19.76 (0.59%)

-19.88 (86.93%)

-152.15 (-755.74%)

Price to Sales Ratio (P/S)

7.41 (-19.40%)

9.2 (0.83%)

9.12 (72.26%)

5.29 (-51.08%)

Price to Book Ratio (P/B)

9.38 (-50.02%)

18.77 (100.43%)

9.37 (68.19%)

5.57 (-47.65%)

Debt to Equity Ratio (D/E)

4.11 (-39.03%)

6.73 (96.70%)

3.42 (43.58%)

2.38 (7.63%)

Earnings Per Share (EPS)

-3.04 (-18.75%)

-2.56 (-34.74%)

-1.9 (-850.00%)

-0.2 (93.71%)

Sales Per Share (SPS)

4.72 (-14.27%)

5.5 (32.84%)

4.14 (-27.95%)

5.75 (10.01%)

Free Cash Flow Per Share (FCFPS)

-3.65 (-57.87%)

-2.31 (-811.02%)

-0.25 (-289.55%)

0.13 (2133.33%)

Book Value Per Share (BVPS)

3.94 (45.69%)

2.7 (-33.13%)

4.04 (-26.19%)

5.47 (2.78%)

Tangible Assets Book Value Per Share (TABVPS)

20.09 (-3.79%)

20.88 (16.90%)

17.86 (-3.55%)

18.52 (9.48%)

Enterprise Value Over EBIT (EV/EBIT)

-18 (45.45%)

-33 (-32.00%)

-25 (90.04%)

-251 (-178.89%)

Enterprise Value Over EBITDA (EV/EBITDA)

-19.08 (47.50%)

-36.34 (-31.28%)

-27.68 (99.87%)

-20,798.35 (-18506.17%)

Asset Turnover

0.24 (-8.61%)

0.27 (12.66%)

0.24 (-28.61%)

0.33 (32.80%)

Current Ratio

8.47 (43.67%)

5.9 (-16.61%)

7.07 (-27.48%)

9.75 (174.00%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$546,227,000 (-64.88%)

-$331,296,000 (-820.06%)

-$36,008,000 (-291.08%)

$18,844,000 (2340.93%)

Enterprise Value (EV)

$6,632,138,154 (-20.65%)

$8,358,523,500 (32.58%)

$6,304,718,191 (26.83%)

$4,970,804,756 (-38.58%)

Earnings Before Tax (EBT)

-$460,068,000 (-37.76%)

-$333,965,000 (-29.45%)

-$257,985,000 (-785.09%)

-$29,148,000 (70.58%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$347,627,000 (-51.14%)

-$230,010,000 (-0.99%)

-$227,758,000 (-95196.23%)

-$239,000 (99.67%)

Invested Capital

$3,859,570,000 (7.59%)

$3,587,424,000 (8.46%)

$3,307,503,000 (20.30%)

$2,749,473,000 (19.29%)

Working Capital

$2,310,972,000 (5.34%)

$2,193,763,000 (16.00%)

$1,891,133,000 (-10.14%)

$2,104,499,000 (37.39%)

Tangible Asset Value

$3,003,675,000 (0.45%)

$2,990,072,000 (18.00%)

$2,533,876,000 (-2.98%)

$2,611,690,000 (10.58%)

Market Capitalization

$5,520,089,154 (-23.95%)

$7,258,254,500 (35.28%)

$5,365,241,191 (24.86%)

$4,297,020,756 (-45.65%)

Average Equity

$452,758,000 (12.00%)

$404,254,250 (-35.36%)

$625,387,000 (-2.49%)

$641,377,750 (-47.25%)

Average Assets

$2,884,957,500 (-2.04%)

$2,945,098,750 (18.62%)

$2,482,768,000 (1.63%)

$2,443,050,750 (-16.16%)

Invested Capital Average

$3,703,433,250 (1.16%)

$3,661,112,000 (19.87%)

$3,054,336,250 (12.10%)

$2,724,636,500 (-5.50%)

Shares

157,897,287 (10.05%)

143,472,119 (1.00%)

142,050,336 (0.60%)

141,210,015 (0.99%)